525 related articles for article (PubMed ID: 1972611)
21. Efficacy of esmolol as a myocardial protective agent during continuous retrograde blood cardioplegia.
Scorsin M; Mebazaa A; Al Attar N; Medini B; Callebert J; Raffoul R; Ramadan R; Maillet JM; Ruffenach A; Simoneau F; Nataf P; Payen D; Lessana A
J Thorac Cardiovasc Surg; 2003 May; 125(5):1022-9. PubMed ID: 12771874
[TBL] [Abstract][Full Text] [Related]
22. [Hemodynamics of coronary surgery patients following magnesium aspartate infusion].
Marichal A; Hess W; Scheiber G
Anaesthesist; 1992 Dec; 41(12):752-9. PubMed ID: 1489073
[TBL] [Abstract][Full Text] [Related]
23. Beneficial hemodynamic and renal effects of intravenous enalaprilat following coronary artery bypass surgery complicated by left ventricular dysfunction.
Wagner F; Yeter R; Bisson S; Siniawski H; Hetzer R
Crit Care Med; 2003 May; 31(5):1421-8. PubMed ID: 12771613
[TBL] [Abstract][Full Text] [Related]
24. Landiolol and esmolol prevent tachycardia without altering cerebral blood flow.
Saito S; Nishihara F; Akihiro T; Nishikawa K; Obata H; Goto F; Yuki N
Can J Anaesth; 2005 Dec; 52(10):1027-34. PubMed ID: 16326671
[TBL] [Abstract][Full Text] [Related]
25. Comparison of hemodynamic changes after acute normovolemic hemodilution using Ringer's lactate versus 5% albumin in patients on beta-blockers undergoing coronary artery bypass surgery.
Arya VK; Nagdeve NG; Kumar A; Thingnam SK; Dhaliwal RS
J Cardiothorac Vasc Anesth; 2006 Dec; 20(6):812-8. PubMed ID: 17138086
[TBL] [Abstract][Full Text] [Related]
26. Clinical rationale for the use of an ultra-short acting beta-blocker: esmolol.
Barbier GH; Shettigar UR; Appunn DO
Int J Clin Pharmacol Ther; 1995 Apr; 33(4):212-8. PubMed ID: 7620691
[TBL] [Abstract][Full Text] [Related]
27. Hemodynamic changes during posterior vessel off-pump coronary artery bypass: comparison between deep pericardial sutures and vacuum-assisted apical suction device.
Chang WI; Kim KB; Kim JH; Ham BM; Kim YL
Ann Thorac Surg; 2004 Dec; 78(6):2057-62. PubMed ID: 15561035
[TBL] [Abstract][Full Text] [Related]
28. [Experiences with parenteral administration of diltiazem in coronary surgery patients].
Kling D; Boldt J; Moosdorf R; Bachmann B; Hempelmann G
Anaesthesist; 1988 Apr; 37(4):249-55. PubMed ID: 3044182
[TBL] [Abstract][Full Text] [Related]
29. Acute effects of nicardipine and esmolol on the cardiac cycle, intracardiac hemodynamic and endothelial shear stress in patients with unstable angina pectoris and moderate coronary stenosis: results from single center, randomized study.
Chen SL; Hu ZY; Zhang JJ; Ye F; Kan J; Xu T; Liu ZZ; Zhang YJ; Zhang JX; Chen M
Cardiovasc Ther; 2012 Jun; 30(3):162-71. PubMed ID: 22099625
[TBL] [Abstract][Full Text] [Related]
30. The safety and efficacy of esmolol during myocardial revascularization.
Girard D; Shulman BJ; Thys DM; Mindich BP; Mikula SK; Kaplan JA
Anesthesiology; 1986 Aug; 65(2):157-64. PubMed ID: 3526984
[TBL] [Abstract][Full Text] [Related]
31. The comparison of dexmedetomidine, esmolol, and combination of dexmedetomidine with esmolol for attenuation of sympathomimetic response to laryngoscopy and intubation in patients undergoing coronary artery bypass grafting.
Singh D; Jagannath S; Priye S; Mudassar AS
Ann Card Anaesth; 2019; 22(4):353-357. PubMed ID: 31621668
[TBL] [Abstract][Full Text] [Related]
32. [Automated, continuous ST segment analysis in the ECG as a monitor of myocardial ischemia during aortocoronary bypass surgery].
Probst S; Wiederspahn T; Dudziak R
Anaesthesist; 1991 Jul; 40(7):380-5. PubMed ID: 1928711
[TBL] [Abstract][Full Text] [Related]
33. The use of esmolol in whole-body hyperthermia: cardiovascular effects.
Berry JM; Michalsen A; Nagle V; Bull JM
Int J Hyperthermia; 1997; 13(3):261-8. PubMed ID: 9222810
[TBL] [Abstract][Full Text] [Related]
34. Comparison of bolus and continuous infusion of esmolol on hemodynamic response to laryngoscopy, endotracheal intubation and sternotomy in coronary artery bypass graft.
Efe EM; Bilgin BA; Alanoglu Z; Akbaba M; Denker C
Braz J Anesthesiol; 2014; 64(4):247-52. PubMed ID: 24998108
[TBL] [Abstract][Full Text] [Related]
35. The effect of single bolus dose of esmolol for controlling the tachycardia and hypertension during laryngoscopy and tracheal intubation.
Yuan L; Chia YY; Jan KT; Chen CS; Wang CH; Haung LH; Kang L
Acta Anaesthesiol Sin; 1994 Sep; 32(3):147-52. PubMed ID: 7921858
[TBL] [Abstract][Full Text] [Related]
36. Esmolol: a new ultrashort-acting beta-adrenergic blocking agent for rapid control of heart rate in postoperative supraventricular tachyarrhythmias.
Gray RJ; Bateman TM; Czer LS; Conklin CM; Matloff JM
J Am Coll Cardiol; 1985 Jun; 5(6):1451-6. PubMed ID: 2860148
[TBL] [Abstract][Full Text] [Related]
37. Systolic-dicrotic notch pressure difference can identify tachycardic patients with septic shock at risk of cardiovascular decompensation following pharmacological heart rate reduction.
Morelli A; Romano SM; Sanfilippo F; Santonocito C; Frati G; Chiostri M; Agrò FE; Ertmer C; Rehberg SW; Vieillard-Baron A
Br J Anaesth; 2020 Dec; 125(6):1018-1024. PubMed ID: 32690246
[TBL] [Abstract][Full Text] [Related]
38. Use of an ultrashort-acting beta-receptor blocker (esmolol) in patients with acute myocardial ischemia and relative contraindications to beta-blockade therapy.
Kirshenbaum JM; Kloner RF; McGowan N; Antman EM
J Am Coll Cardiol; 1988 Sep; 12(3):773-80. PubMed ID: 2900259
[TBL] [Abstract][Full Text] [Related]
39. Cardiovascular interactions of halothane anesthesia and nifedipine in patients subjected to elective coronary artery bypass surgery.
Schulte-Sasse U; Hess W; Markschies-Hornung A; Tarnow J
Thorac Cardiovasc Surg; 1983 Oct; 31(5):261-5. PubMed ID: 6196857
[TBL] [Abstract][Full Text] [Related]
40. Use of esmolol in hypertension after cardiac surgery.
Gray RJ; Bateman TM; Czer LS; Conklin C; Matloff JM
Am J Cardiol; 1985 Oct; 56(11):49F-56F. PubMed ID: 2864849
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
